Table 1 Reported performances of the thermodynamic solubility models published from 1997 to 2007.
From: Will we ever be able to accurately predict solubility?
Year | Reference | Descriptors | Size | Dataset | Method | RMSE | R2 |
|---|---|---|---|---|---|---|---|
1997 | Huuskonen et al.87 | Electrotopological / Topological | 83 | Litterature | ANN | — | 0.84 |
2000 | Huuskonen et al.16 | Structural | 694 | Khune et al. | MLR | — | 0.67 |
0.87 | |||||||
ANN | 0.85 | ||||||
0.84 | |||||||
2001 | Tetko et al.23 | Molconn-Z | 1,291 | Huuskonen et al. | MLR | 0.81 | 0.85 |
ANN | 0.66 | 0.9 | |||||
Ran et al.42 | Melting Point / cLogP | 380 | AquaSol | GSE | 0.76 | — | |
Bruneau88 | 2D/3D/Charge/ Katrizky | 2,233 | Huuskonen et al. | ANN | 0.82 | — | |
Liu et al.89 | 2D Topological | 1,312 | Huuskonen et al. | ANN | 0.71 | — | |
2002 | Klamt et al.90 | QM | 257 | QikProp dataset | MLR | 0.61 | — |
Engkvist et al.91 | 1D/2D Descriptors | 1,290 | Huuskonen et al. | ANN | — | 0.95 | |
Chen et al.92 | Dipole, PSA, Vol, MW, Rot. & H-acc/don and D | 321 | Litterature | MLR | 0.86 | 0.71 | |
2003 | Wegner & Zell93 | 2D Topological | 1,290 | Huuskonen et al. | ANN | 0.54 | — |
Cheng & Merz94 | Cerius | 2,440 | AquaSol, PhysProp, Merck Index, PDR, CMC | MLR-GA | 1.01 | — | |
Yan & Gasteiger95 | PETRA | 1,293 | Huuskonen et al. | MLR | — | 0.89 | |
ANN | 0.94 | ||||||
Lind & Maltseva96 | Electrostatic, QM & topological | 1,296 | Huuskonen et al. | SVM | 0.68 | 0.89 | |
2004 | Yan et al.97 | PETRA | 2,084 | Huuskonen et al. | ANN | — | 0.94 |
Hou et al.98 | 2D Topological | 1,299 | Huuskonen et al. | MLR | — | 0.9 | |
Fröhlich et al.99 | MOE & JOElib | 1,297 | Huuskonen et al. | SVM | — | 0.9 | |
Votano et al.100 | Fragments & Counts | 4,115 | Aquasol, Physprop, PDR, Taskinen, Tetko, Lobell | MLR & PLS | — | 0.84 | |
ANN | 0.84 | ||||||
1,840 | ANN | 0.86 | |||||
John S. Delaney19 | cLogP, MW & Count | 2,874 | Abraham, Pesticide Manual, Syngenta | ESOL | — | 0.55 | |
2005 | Matthew Clark101 | 2D descriptors | 3,724 | PhysProp | PLS | — | 0.84 |
Catana et al.102 | MOE, E-state & ISIS key | 1,107 | Pfizer proprietary & Public | PLS | 0.48 | 0.94 | |
Non-Linear PLS | |||||||
NN | |||||||
2006 | Hansen et al.43 | MOE 2D/3D | 4,569 | PhysProp | ANN | 0.97 | 0.94 |
Wassvik et al.103 | Tm, LogP, Sm, Hm & Molconn-Z | 428 | Astrazeneca | GSE | 0.92 | 0.73 | |
Mod. GSE | 0.73 | 0.78 | |||||
2007 | Wang et al.10 | 3D Topological, cLogP, MW & Count | 1,878 | Delaney et al., Huuskonen et al., Hou et al. | MLR | 0.74 | 0.9 |
Johnson et al.45 | VOLSURF | 362 | Literature | MLR & HH | 0.61 | 0.88 | |
Schwaighofer et al.104 | Dragon | 1,290 | Huuskonen et al. | GP | 0.55 | 0.93 | |
4,597 | Huuskonen et al. & Others | 0.55 | 0.91 |